83,682 Shares in Corteva, Inc. $CTVA Purchased by Sanctuary Advisors LLC

Sanctuary Advisors LLC acquired a new position in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 83,682 shares of the company’s stock, valued at approximately $7,087,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in Corteva by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock valued at $5,398,392,000 after purchasing an additional 317,538 shares during the period. BlackRock Inc. purchased a new position in shares of Corteva during the 2nd quarter valued at $4,560,180,000. State Street Corp grew its stake in shares of Corteva by 3.7% during the 4th quarter. State Street Corp now owns 36,570,876 shares of the company’s stock worth $2,451,346,000 after acquiring an additional 1,290,071 shares during the period. Franklin Resources Inc. increased its holdings in Corteva by 4.3% in the 4th quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after acquiring an additional 805,873 shares during the last quarter. Finally, Harris Associates L P raised its stake in Corteva by 168.1% in the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after acquiring an additional 10,675,052 shares during the period. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Stock Up 1.2%

Shares of NYSE CTVA opened at $82.74 on Tuesday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The company has a market cap of $55.21 billion, a P/E ratio of 54.80, a P/E/G ratio of 2.51 and a beta of 0.57. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $90.97. The business has a 50-day simple moving average of $82.27 and a two-hundred day simple moving average of $80.32.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same period in the prior year, the business posted $2.20 earnings per share. The company’s revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s dividend payout ratio is 47.68%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Jefferies Financial Group upped their price objective on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Morgan Stanley boosted their price target on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Barclays upped their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. Rothschild & Co Redburn raised their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Finally, Royal Bank Of Canada lifted their price objective on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research note on Tuesday, July 21st. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.